Immunotherapy of urothelial neoplasms. Experimental and clinical implications of alpha interferon
Carballido, J.; Alvarez-Mon, M.; Olivier, C.; Moltó, L.
Archivos Espanoles de Urologia 43(Suppl 2): 149-158
1990
ISSN/ISBN: 0004-0614 PMID: 2096776 Document Number: 354842
Document emailed within 1 workday
Related Documents
Eriksson, O.; Johansson, S. 1976: Urothelial neoplasms of the upper urinary tract. a correlation between cytologic and histologic findings in 43 patients with urothelial neoplasms of the renal pelvis or ureter Acta Cytologica 20(1): 20-25Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Stathopoulos, G.P.; Baxevanis, C.N.; Papadopoulos, N.G.; Zarkadis, I.K.; Papacostas, P.; Michailakis, E.; Tsiatas, M.L.; Papamichail, M. 1996: Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters Anticancer Research 16(6b): 3855-3860
Trnĕný, M.; Apltauerová, M.; Procházka, B.; Klener, P. 1999: Administration of interferon alpha as post-transplantation immunotherapy in malignant lymphoma. Case control study Casopis Lekaru Ceskych 138(22): 689-692
Keilholz, U.; Scheibenbogen, C.; Stoelben, E.; Saeger, H.D.; Hunstein, W. 1994: Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions European Journal of Cancer 30a(7): 955-958
Tilz, G.P.; Lanzer, G. 1980: Immunotherapy II: clinical investigations for the induction and activity of interferon Acta Medica Austriaca 7(3): 77-79
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Pascal, A.; Dobromir, N.; Ivan, L.ţa. 2009: Clinical and morphological features of a non-invasive papillary urothelial carcinoma, evolving from a urothelial inverted papilloma of the bladder Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 113(1): 150-153
Konjević, G.; Jović, V.; Radulović, S.; Jelić, S.; Dzodić, R.; Spuzić, I. 2001: Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha Neoplasma 48(3): 175-181
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Langstein, H.N.; Doherty, G.M.; Fraker, D.L.; Buresh, C.M.; Norton, J.A. 1991: The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia Cancer Research 51(9): 2302-2306
Yu, S.S.; Dorff, T.B.; Ballas, L.K.; Sadeghi, S.; Skinner, E.C.; Quinn, D.I. 2017: Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease Clinical Advances in Hematology and Oncology: H&o 15(6): 466-477
Rockey, D.C.; Chung, J.J. 1994: Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 42(4): 660-670
Bernasconi, C. 1990: Clinical use of alpha-interferon in onco-hematology: conclusions and prospects Haematologica 75(Suppl 4): 82-84
Pazdur, R.; Bready, B.; Moore, D.F. 1991: Clinical trials of fluorouracil with alpha-interferon in advanced colorectal carcinomas Seminars in Oncology 18(5 Suppl 7: 67-70
Cooper, M.R. 1991: A review of the clinical studies of alpha-interferon in the management of multiple myeloma Seminars in Oncology 18(5 Suppl 7: 18-29
Privitera, G.; Auxilia, F.; Bosisio, C.; Castaldi, S.; Pagano, A. 1996: Application of clinical audit to the evaluation of prescription of interferon-alpha in a teaching hospital Epidemiologia E Prevenzione 20(1): 11-17
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Koyama, S.; Narita, M. 1988: In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1540-1549